title: Health physics aspects of neutron activated components in a linear accelerator.
abstract: The purpose of this study was to investigate the residual radioactivity in the therapy accessories of a medical x ray linear accelerator. The residual radioactivity mainly originated from nuclear activation reactions by neutrons, which are present as a contamination radiation in the x-ray beam. The radiation used in this study was the 25 MV x-ray beam produced by a CGR Saturne III linear accelerator. The five treatment aids include four wedges of various angles and one cerrobend block. The decrease in dose rates with time was followed for 60 min for each of the five treatment aids immediately after 999 monitor units of irradiation. The integral doses from the surface of each of four activated therapy accessories following three different radiation doses were measured by using thermoluminescent dosimeters (CaF2). In the TLD measurement, polyethylene filters were used to differentiate beta or beta particles from the mixed decay radiation. A high-purity germanium detection system was utilized to collect and to analyze the gamma spectra from the activated therapy accessories. The residual radioisotopes found in the 15 degree wedge and 30 degree wedge included V, Cr, Cr, Mn, Fe, Co, and Ni. In the 45 degree and 60 degree wedges, the radionuclides identified were Co, Ni, Cu, and W. The principal nuclides identified in the irradiated cerrobend block were In, Sn, Cd, Pb. The corresponding nuclear reactions from which the residual radionuclides produced were confirmed by consulting the current literature.
authors.affiliation: Radiation Safety Office, Columbia University Medical Center, New York, NY 10032, USA. sg2059@columbia.edu
authors.forename: Shuntong
authors.initials: S
authors.lastname: Guo
authors.forename: Paul L
authors.initials: PL
authors.lastname: Ziemer
mesh_terms: D004866:Equipment Contamination; D019544:Equipment Failure Analysis / Q000379:methods*; D006283:Health Physics / Q000295:instrumentation* / Q000379:methods*; D009502:Neutrons; D009683:Nuclear Medicine; D016273:Occupational Exposure / Q000032:analysis; D010315:Particle Accelerators / Q000295:instrumentation*; D011829:Radiation Dosage; D011835:Radiation Protection / Q000379:methods*; D011874:Radiometry / Q000295:instrumentation / Q000379:methods*; D018570:Risk Assessment / Q000379:methods